Markt für Hämodialyse und Peritonealdialyse – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPHE100001128
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 177
Buy Now

Der Markt für Hämodialyse und Peritonealdialyse soll bis 2028 130.370,18 Millionen US-Dollar erreichen, gegenüber 89.851,61 Millionen US-Dollar im Jahr 2022; es wird erwartet, dass es von 2022 bis 2028 mit einer CAGR von 6,4 % wachsen wird.



Es gibt zwei Arten der Dialyse. Bei der Hämodialyse wird Blut aus dem Körper des Patienten zu einer künstlichen Nierenmaschine gepumpt und über Schläuche, die mit den Maschinen verbunden sind, in den Körper des Patienten zurückgeführt. Bei der Peritonealdialyse fungiert die innere Auskleidung des eigenen Bauches des Patienten als natürlicher Filter.



Der Markt für Hämodialyse und Peritonealdialyse ist nach Typ, Produkt, Endverbraucher und Erdkunde. Geografisch ist der Markt grob in Nordamerika, Europa, den asiatisch-pazifischen Raum, den Nahen Osten und Afrika sowie Süd- und Mittelamerika unterteilt. Der Hämodialyse und Peritonealdialyse-Marktbericht bietet Einblicke und eingehende Analysen des Marktes, wobei Parameter wie Marktgröße, Trends, technologischer Fortschritt und Marktdynamik sowie die Analyse der Wettbewerbslandschaft der weltweit führenden Marktteilnehmer hervorgehoben werden. Darüber hinaus enthält der Bericht die Auswirkungen der COVID-19-Pandemie auf den Markt für Hämodialyse und Peritonealdialyse in allen Regionen.





>Das Wachstum des Marktes für Hämodialyse und Peritonealdialyse wird auf die Zunahme der Zahl der ESRD-Patienten, die steigende Inzidenz von Nierenversagen und chronischer Nierenfunktionsstörung in der Bevölkerung und den Mangel an Organspendern zurückgeführt. Allerdings schränken die Erstattungsbedenken in Schwellenländern das Marktwachstum ein.



Strategische Erkenntnisse



Lukrative Regionen für den Hämodialyse- und Peritonealdialysemarkt< /h3>

Markteinblicke



Zunehmende Prävalenz von Nierenerkrankungen treibt das Marktwachstum für Hämodialyse und Peritonealdialyse voran



< p> Chronische Nierenerkrankung (CKD) und akutes Nierenversagen (AKI) sind Erkrankungen, bei denen die Nieren geschädigt sind und das Blut nicht richtig filtern können. Aus diesem Grund verbleiben überschüssige Flüssigkeit und Blutabfälle im Körper, was andere Gesundheitsprobleme wie Herzerkrankungen und Schlaganfälle verursachen kann. CKD verschlechtert sich normalerweise im Laufe der Zeit, obwohl die Behandlung einen langsamen Fortschritt gezeigt hat. Wenn CNE unbehandelt bleibt, kann es zu Nierenversagen und frühen Herz-Kreislauf-Erkrankungen kommen. Wenn die Nieren bei CKD nicht mehr funktionieren, ist eine Dialyse oder eine Nierentransplantation zum Überleben erforderlich. Bei Behandlung mit Dialyse oder Nierentransplantation wird dieses Nierenversagen als terminale Niereninsuffizienz (ESRD) bezeichnet. Nach Angaben der Centers for Disease Control and Prevention (CDC) leiden in den USA etwa 36 Millionen Erwachsene an CNI. Außerdem beginnen alle 24 Stunden 360 Menschen mit einer Dialysebehandlung wegen Nierenversagens. Im Jahr 2017 wurden weltweit 697,5 Millionen Fälle von CKD (alle Stadien) registriert, was einer globalen Prävalenz von 9,1 % entspricht. Die zunehmende Prävalenz von ESRD ist auch einer der Hauptfaktoren, die den Markt antreiben. Laut dem United States Renal Data System (USRDS) leben beispielsweise fast 786.000 Menschen im Land mit einer Nierenerkrankung im Endstadium (ESKD), die auch als Nierenerkrankung im Endstadium (ESRD) bekannt ist. Daher treibt die zunehmende Prävalenz chronischer Nierenerkrankungen, akuter Nierenschäden und Nierenerkrankungen im Endstadium, die zur Dialyseerkrankung führen, den Markt für Hämodialyse und Peritonealdialyse voran.



Typbasierte Einblicke



Je nach Typ wird der Markt für Hämodialyse und Peritonealdialyse in Hämodialyse und Peritonealdialyse unterteilt. Im Jahr 2022 hatte das Segment Hämodialyse einen größeren Marktanteil. Darüber hinaus wird erwartet, dass dasselbe Segment im Prognosezeitraum eine höhere CAGR von 6,7 % verzeichnet.



Markt für Hämodialyse und Peritonealdialyse, nach Typ - 2022 und 2028

< TIP>

Produktbasierte Einblicke



Basierend auf dem Produkt wird der Hämodialyse- und Peritonealdialysemarkt in Geräte, Verbrauchsmaterialien und Dienstleistungen unterteilt. Das Dienstleistungssegment hielt im Jahr 2022 den größten Marktanteil. Das Verbrauchsgütersegment wird jedoch voraussichtlich im Prognosezeitraum die höchste CAGR von 7,5 % verzeichnen.



Endnutzerbasierte Erkenntnisse< /h3>

Basierend auf dem Endnutzer wird der Hämodialyse- und Peritonealdialysemarkt in Krankenhaus- und Heimanwendungen unterteilt. Das Krankenhaussegment hatte im Jahr 2022 einen größeren Anteil. Es wird jedoch erwartet, dass das Heimsegment im Prognosezeitraum eine höhere CAGR von 7,4 % verzeichnet.





Die Hämodialyse- und Peritonealdialyse-Marktteilnehmer verfolgen organische Strategien wie Produkteinführung und -erweiterung, um ihre Präsenz und ihr Produktportfolio weltweit zu erweitern und den wachsenden Anforderungen gerecht zu werden.



Nach Geographie



Basierend auf der Geographie ist der Markt für Hämodialyse und Peritonealdialyse in Nordamerika (USA, Kanada und Mexiko) und Europa unterteilt (Großbritannien, Deutschland, Frankreich, Italien, Spanien und das restliche Europa), Asien-Pazifik (China, Japan, Indien, Australien, Südkorea und der Rest des asiatisch-pazifischen Raums), Naher Osten und Afrika (die Vereinigten Arabischen Emirate, Saudi-Arabien, Südafrika und der Rest des Nahen Ostens und Afrikas) sowie Süd- und Mittelamerika (Brasilien, Argentinien und der Rest von Süd- und Mittelamerika). Einige der führenden Akteure auf dem Markt sind Fresenius Medical Care AG & Co KGaA; DaVita Inc.; Baxter International Inc.; B. Braun Melsungen AG; Diaverum; Nipro Medical Corporation; Asahi Kasei Medical Co., Ltd.; Rockwell Medical, Inc.; und Dialife SA.



Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the hemodialysis and peritoneal dialysis market?

Hemodialysis and peritoneal dialysis are performed for patients suffering from chronic kidney disease and acute kidney injury. Hemodialysis helps in removing waste from body such as urea from the blood, along with maintaining proper balance of electrolytes in the blood. Peritoneal dialysis procedures are conducted in lining of the abdomen to filter the blood in people who suffer from kidney failures.

What are the driving factors for the hemodialysis and peritoneal dialysis market across the globe?

Key factors that are driving the growth of this market are increasing prevalence of kidney diseases, and increasing prevalence of diabetes.

Which type led the hemodialysis and peritoneal dialysis market?

The hemodialysis segment dominated the global hemodialysis and peritoneal dialysis market and held the largest revenue share of 86.09% in 2022.

Which product led the hemodialysis and peritoneal dialysis market?

The services segment dominated the global hemodialysis and peritoneal dialysis market and held the largest revenue share of 60.98% in 2022.

Which end user led the hemodialysis and peritoneal dialysis market?

The hospital-based segment dominated the global hemodialysis and peritoneal dialysis market and held the largest revenue share of 84.16% in 2022.

Who are the major players in market the hemodialysis and peritoneal dialysis market?

The hemodialysis and peritoneal dialysis market majorly consists of the players such as Fresenius Medical Care AG & Co KGaA; DaVita Inc.; Baxter International Inc.; B. Braun Melsungen AG; Diaverum; Nipro Medical Corporation; Evoqua Water Technologies LLC. (Mar Cor Purification); Asahi Kasei Medical Co., Ltd.; Rockwell Medical, Inc.; Dialife SA; amongst others.

What is the regional market scenario of hemodialysis and peritoneal dialysis market?

Global hemodialysis and peritoneal dialysis market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for transport media. The US is estimated to hold the largest share in the hemodialysis and peritoneal dialysis market during the forecast period. The rising prevalence of chronic kidney disease and healthcare spending by Medicare contributes to the market's growth. However, the prevalence of chronic kidney disease (CKD) that demands promising diagnostic test options in the Asia-Pacific is expected to account for the fastest growth of the region during the coming years

The List of Companies - Hemodialysis And Peritoneal Dialysis Market
  1. Fresenius Medical Care AG & Co KGaA
  2. DaVita Inc.
  3. Baxter International Inc.
  4. B. Braun Melsungen AG
  5. Diaverum
  6. Nipro Medical Corporation
  7. Evoqua Water Technologies LLC. (Mar Cor Purification)
  8. Asahi Kasei Medical Co., Ltd.
  9. Rockwell Medical, Inc.
  10. Dialife SA

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports